| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kalra Balkrishan | President and CEO, Director | C/O GENPACT LLC, 521 FIFTH AVENUE, 14TH FLOOR, NEW YORK | /s/ Thomas D. Scholtes, as Attorney-in-fact for Balkrishan Kalra | 15 Sep 2025 | 0001768217 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | G | Common Shares | Sale | -$651K | -15K | -4.83% | $43.39 | 295K | 11 Sep 2025 | Direct | F1 |
| transaction | G | Common Shares | Options Exercise | $1.11M | +40K | +13.55% | $27.65 | 335K | 11 Sep 2025 | Direct | |
| transaction | G | Common Shares | Sale | -$1.73M | -40K | -11.93% | $43.35 | 295K | 11 Sep 2025 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | G | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -40K | -93.46% | $0.00 | 2.8K | 11 Sep 2025 | Common Shares | 40K | $27.65 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.39 to $43.40. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F2 | The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.29 to $43.42. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F3 | The option vested 50% on January 10, 2019 and the remainder on January 10, 2021. |